Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
44 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001125-DK
Optimizing HBV Care Cascade among Foreign-Born in the United States (FOCUS-HBV Study)
Participants currently recruited/enrolled
18-100 Years
NIDDK
Hepatitis
000958-C
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by Invitation
18-125 Years
NCI
Hepatitis
000826-C
An Open Label, Randomised, Phase 2 Study to Evaluate the Safety and Efficacy of MTL-CEBPA Administered in Combination with Sorafenib or Sorafenib Alone, in TKI Naive Participants with Previously Treated Advanced Hepatocellular Carcinoma (HCC) and Hepatit
Recruitment has not started
18-125 Years
NCI
Hepatitis
000444-H
Vaccine Responses in Patients with B Cell Malignancies
Participants currently recruited/enrolled
18-125 Years
NHLBI
Hepatitis
000118-DK
Prospective Cohort Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects with Chronic Liver Disease
Participants currently recruited/enrolled
18-100 Years
NIDDK
Hepatitis
21-C-0023
A Phase I Study of Pomalidomide and Nivolumab in Patients with Virus-Associated Malignancies With or Without HIV
Participants currently recruited/enrolled
18-125 Years
NCI
Hepatitis
20-DK-0067
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared with PEG IFN-alfa-2a Monotherapy and Placebo Treatment i
No longer recruiting/follow-up only
18-125 Years
NIDDK
Hepatitis
20-C-0011
Phase 1 Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Completed Study; data analyses ongoing
18-125 Years
NCI
Hepatitis
19-CC-0055
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes after Hepatitis C Eradication
Participants currently recruited/enrolled
18-125 Years
CC
Hepatitis
18-I-0101
Sample Collection From Healthy Volunteers for Assay Optimization
Participants currently recruited/enrolled
18-125 Years
NIAID
Hepatitis
18-DK-0123
Treatment of Chronic Delta Hepatitis with Lonafarnib, Ritonavir and Lambda Interferon
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
18-DK-0091
Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Participants currently recruited/enrolled
18-125 Years
NIDDK
Hepatitis
18-CC-0087
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers
Completed Study; data analyses ongoing
18-65 Years
CC
Hepatitis
17-I-0067
Sanaria PfSPZ Challenge with Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Dose Escalation Trial to Determine Safety and Development of Protective Efficacy after Exposure to Only Pre-erythrocytic Stages of Plasmodium falciparum
Completed Study; data analyses ongoing
18-50 Years
NIAID
Hepatitis
17-C-0048
Anti-CD30 CAR T Cells with Fully-human Binding Domains for Treating CD30-expressing Lymphomas Including Anaplastic Large Cell Lymphomas
Completed Study; data analyses ongoing
18-73 Years
NCI
Hepatitis
16-DK-0143
Idiosyncratic Liver Injury Associated with Drugs (ILIAD): A Retrospective Study
Participants currently recruited/enrolled
18-125 Years
NIDDK
Hepatitis
16-DA-N140
Effects of a New Behavioral Intervention on Alcohol Craving and Drinking
Participants currently recruited/enrolled
21-65 Years
NIDA
Hepatitis
15-DK-0170
Treatment of Chronic Delta Hepatitis with Lonafarnib and Ritonavir
Completed Study; data analyses ongoing
18-99 Years
NIDDK
Hepatitis
15-DK-0143
Investigation of Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected with Different Hepatitis C Virus Genotypes During Therapy with Sofosbuvir and GS-5816
Completed Study; data analyses ongoing
18-80 Years
NIDDK
Hepatitis
15-DK-0100
A Multidisciplinary Approach to Deciphering the Mechanisms Involved In Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
15-DK-0082
Mechanisms Associated with Favorable Response to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
15-DK-0079
Observational Study of Hepatitis B Virus (HBV) in Patients Coinfected with Human Immunodeficiency Virus (HIV)
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
13-DK-0091
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir DF versus Tenofovir DF Monotherapy in HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
12-DK-0071
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-40 Years
NIDDK
Hepatitis
11-I-0183
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Participants currently recruited/enrolled
18-65 Years
NIAID
Hepatitis
11-I-0057
Effect of Interferon Alpha 2b Intensification on HIV-1 Residual Viremia in Individuals Suppressed on Antiretroviral Therapy
Completed Study; data analyses ongoing
18-65 Years
NIAID
Hepatitis
11-DK-0151
Withdrawal of Therapy After Long-Term Oral Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B
Completed Study; data analyses ongoing
18-125 Years
NIDDK
Hepatitis
11-DK-0108
Observational Study of Persons with Hepatitis B Virus Infection in North America (Cohort Study)
Completed Study; data analyses ongoing
18-100 Years
NIDDK
Hepatitis
11-CC-0152
The Natural History of Liver Disease in a Cohort of Participants with Hepatitis B and/or Hepatitis C with or without HIV Infection
Completed Study; data analyses ongoing
18-99 Years
CC
Hepatitis
10-CC-0053
Collection of Bone Marrow from Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
Completed Study; data analyses ongoing
18-125 Years
CC
Hepatitis
10-C-0201
Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells from Patients with DOCK8 Deficiency, LAD-1, and GATA2 Deficiency
Participants currently recruited/enrolled
18-40 Years
NCI
Hepatitis
09-I-0200
A Phase I Study of MozobilTM in the Treatment of Patients with WHIMS
Participants currently recruited/enrolled
18-75 Years
NIAID
Hepatitis
09-I-0126
Pathogenesis and Genetic Basis of Physical Induced Urticarial Syndromes
Participants currently recruited/enrolled
2-90 Years
NIAID
Hepatitis
09-I-0013
Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults
Enrolling by Invitation
18-100 Years
NIAID
Hepatitis
08-DK-0149
High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed after Standard Therapy
Completed Study; data analyses ongoing
18-65 Years
NIDDK
Hepatitis
06-I-0153
A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy
No longer recruiting/follow-up only
18-100 Years
NIAID
Hepatitis
03-I-0263
VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies
Participants currently recruited/enrolled
18-125 Years
NIAID
Hepatitis
02-I-0086
Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity
Participants currently recruited/enrolled
18-125 Years
NIAID
Hepatitis
01-CC-0231
A Prospective Study of Transfusion-Transmitted Infections
Completed Study; data analyses ongoing
0-125 Years
CC
Hepatitis
01-CC-0045
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis
Participants currently recruited/enrolled
18-125 Years
CC
Hepatitis
91-I-0140
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in HIV-Infected and HIV-Uninfected Volunteers
Participants currently recruited/enrolled
18-125 Years
NIAID
Hepatitis
91-DK-0214
Evaluation of Patients with Liver Disease
Participants currently recruited/enrolled
2-125 Years
NIDDK
Hepatitis
91-CC-0117
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population
No longer recruiting/follow-up only
18-125 Years
CC
Hepatitis
81-I-0164
Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies
Participants currently recruited/enrolled
18-125 Years
NIAID
Hepatitis